New York State Common Retirement Fund
DFTX

New York State Common Retirement Fund’s Definium Therapeutics DFTX Stock Holding History

New York State Common Retirement Fund’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
45,800
+16,200
+55% +$400K ﹤0.01% 1436
2026
Q1 		$559K Hold
29,600
– – ﹤0.01% 1866
2025
Q4 		$396K Buy
29,600
+12,500
+73% +$155K ﹤0.01% 2046
2025
Q3 		$202K Hold
17,100
– – ﹤0.01% 2290
2025
Q2 		$111K Hold
17,100
– – ﹤0.01% 2517
2025
Q1 		$100K Hold
17,100
– – ﹤0.01% 2511
2024
Q4 		$119K Hold
17,100
– – ﹤0.01% 2519
2024
Q3 		$97.3K Sell
17,100
-12,000
-41% -$83.5K ﹤0.01% 2596
2024
Q2 		$210K Buy
+29,100
New +$255K ﹤0.01% 2404
2022
Q3 		– Sell
-204
Closed -$2K – 3386
2022
Q2 		$2K Sell
204
-13,567
-99% -$172K ﹤0.01% 3294
2022
Q1 		$229K Buy
13,771
+20
+0.1% +$347 ﹤0.01% 2774
2021
Q4 		$285K Sell
13,751
-44
-0.3% -$1.4K ﹤0.01% 2732
2021
Q3 		$482K Sell
13,795
-4,598
-25% -$199K ﹤0.01% 2484
2021
Q2 		$952K Buy
+18,393
New +$966K ﹤0.01% 2262

Other funds holding DFTX

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

New York State Common Retirement Fund's DFTX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Definium Therapeutics (DFTX) stake by 55% in Q2 2026, buying an estimated $400K and bringing the position to 45,800 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

New York State Common Retirement Fund first reported a position in DFTX in Q2 2021 and has held it in 14 quarters since. 102 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • New York State Common Retirement Fund held 45,800 shares of Definium Therapeutics worth $2.15M as of Q2 2026.
  • New York State Common Retirement Fund bought 16,200 Definium Therapeutics shares in Q2 2026, an estimated $400K.
  • Definium Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1436 holding.
  • New York State Common Retirement Fund first reported a position in Definium Therapeutics in Q2 2021 and has held it in 14 quarters since.
  • 102 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.